about
Anti-inflammatory activity of a novel family of aryl ureas compounds in an endotoxin-induced airway epithelial cell injury modelInhibition of endotoxin-induced airway epithelial cell injury by a novel family of pyrrol derivates.Selenoureido-iminosugars: A new family of multitarget drugs.Mitotic arrest induced by a novel family of DNA topoisomerase II inhibitors.Abietane diterpenoids from Salvia pachyphylla and S. clevelandii with cytotoxic activity against human cancer cell lines.Derivatives of grindelic acid: from a non-active natural diterpene to synthetic antitumor derivatives.Molecular docking studies of the interaction between propargylic enol ethers and human DNA topoisomerase IIα.Antiproliferative and quinone reductase-inducing activities of withanolides derivatives.Synthesis and identification of unprecedented selective inhibitors of CK1ε.Synthesis and antiproliferative activity of glutamic acid-based dipeptides.Reactivity and biological properties of a series of cytotoxic PtI2(amine)2 complexes, either cis or trans configured.Synthesis and in vitro antiproliferative activities of (5-aryl-1,2,4-oxadiazole-3-yl) methyl d-ribofuranosides.Synthesis of monomeric and dimeric steroids containing [1,2,4]triazolo[1,5-a]pyrimidines.Synthesis and biological evaluation of crown ether acyl derivatives.Synthesis and antiproliferative activity of peracetylated 2-amino-1,2-dideoxy-1-nitro-d-glycero-l-manno and d-glycero-d-talo heptitols.Influence of the configurational pattern of sp(2)-iminosugar pseudo N-, S-, O- and C-glycosides on their glycoside inhibitory and antitumor properties.Ring-closing metathesis as key step in the synthesis of Luffarin I, 16-epi-Luffarin I and Luffarin A.Antiproliferative and Structure Activity Relationships of Amaryllidaceae Alkaloids.Antiproliferative effect of extract from endophytic fungus Curvularia trifolii isolated from the "Veracruz Reef System" in Mexico.Dienamine and Friedel-Crafts one-pot synthesis, and antitumor evaluation of diheteroarylalkanals.Synthesis and bioactivity of Luffarin I.Biomimetic synthesis of two salmahyrtisanes: salmahyrtisol A and hippospongide A.Phenolic thio- and selenosemicarbazones as multi-target drugs.Synthesis and biological activity of polyalthenol and pentacyclindole analogues.Novel clioquinol and its analogous platinum complexes: importance, role of the halogen substitution and the hydroxyl group of the ligand.Synthesis and antiproliferative activity of the heterobimetallic complexes [RuClCp(PPh₃)-μ-dmoPTA-1κP:2κ²N,N'-MCl₂] (M = Co, Ni, Zn; dmoPTA = 3,7-dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane).Cytotoxic Profile and Peculiar Reactivity with Biomolecules of a Novel "Rule-Breaker" Iodidoplatinum(II) Complex.Antiproliferative activity of epi-cercosporin in human solid tumor cell lines.Expanding the synthesis of new trans-sulfonamide platinum complexes: cytotoxicity, SAR, fluorescent cell assays and stability studies.Cytotoxic bioactivity of some phenylpropanoic acid derivatives.β-Lapachone analogs with enhanced antiproliferative activity.A modular approach to trim cellular targets in anticancer drug discovery.Antiproliferative activity of dmoPTA-Ru(II) complexes against human solid tumor cells.Antiproliferative effects of novel aliphatic acetogenin analogs against aggressive solid tumor cell lines.Antiproliferative activity of synthetic naphthoquinones related to lapachol. First synthesis of 5-hydroxylapachol.Enhancement of antiproliferative activity by molecular simplification of catalpol.Antiproliferative activity of novel benzo[b][1,6]naphthyridines in human solid tumor cell lines.Tessaric acid derivatives induce G2/M cell cycle arrest in human solid tumor cell lines.Synthesis and antiproliferative activity of 2,4-disubstituted 6-aryl-7H-pyrrolo[3,2-d]pyrimidin-7-one 5-oxides.ent-Labdane Diterpenoids from the Aerial Parts of Eupatorium obtusissmum.
P50
Q28485098-EABE2135-4DBC-46D1-BAB3-CAD914DAB8CCQ31061400-02F90468-327D-46CF-8BD6-A6F78B3EB0F7Q31118637-7E1B47F9-EA44-4D62-BA8B-1E284E518C3EQ33560233-83DDF618-6140-49D8-8F20-870B2A72E9B8Q34594926-00F3723A-C498-4045-9329-7247BEBCE0A4Q34801193-8BC5F841-5338-486D-AA82-E2217545C6BBQ34953354-E4A65D4D-0E79-4A51-80D1-6F0523787404Q35176662-B91E3F15-7DF6-4E1A-BA4D-23B7DA72C426Q35610987-65C54A05-3C43-4CD4-B378-1A6DE2FEAAB2Q35611178-85897FA0-5D25-429B-908D-67B02058B3E9Q38328964-7AFC152C-6501-4FC1-9AEB-08BAEB1F6D73Q38697066-0B0E5D9F-C847-4DB4-97D1-46A21E7F941BQ38738411-09BE3729-5FAB-4466-8FC7-BCB0512A2EB9Q38739300-69645022-15F6-4E1F-A439-0F0E53B90BFCQ38742885-FA47179A-CB7D-4B67-AAC0-CFEE319F97C8Q38796094-788E3FBE-4C49-463A-801C-4EB727677117Q38826318-7826BCF1-086D-40C6-B7EC-00F8E573D4D5Q38844470-7D923D6B-CE8B-4904-9E31-AAB5B74A9A52Q38877736-70738E3A-83DE-4F60-B815-A87C1ACE29BCQ38883053-0CCFEA95-5FEF-45B5-A02A-50CF06F90376Q38883445-D7C56B0B-23C5-4D3A-9F7D-F1CF84FC501DQ38889764-27464837-D14D-4FE8-B43D-01BF3C4400BCQ38902141-074D4F12-6C50-47F8-9641-1CEEDA8B6A5FQ39035423-0B84B5CE-DE71-4EBF-8B83-58929561E190Q39110246-69889D27-3D2A-4B12-A0D6-C6721089D68CQ39133941-E8EC0A14-CD4E-411B-B2E8-3D6DCDC9D9F7Q39155790-E1E024BA-D70B-4BE1-BD0D-D3B7F0029119Q39178159-E979BF4E-5073-4E8F-82DF-674EAAB430D8Q39183170-130FDEED-44AD-4C25-AF80-20777C7E036AQ39243885-CA22C6FA-AA98-461C-A193-43D887A2903CQ39353447-EBB33675-097E-41CB-8AD5-29F45E5E44D5Q39460468-B84A5642-1C76-4DC0-A543-B656D71D630EQ39515121-422762B9-6CF4-46E8-9CAE-09F4E562FCFCQ39562959-71F7AC3E-F496-4CC8-8F9D-1B93C5B49900Q39725259-ABA4BA8F-A039-4AE6-BC94-0B4DA658E158Q39727486-F16D5EA3-B528-4AEB-B57E-2D72AE72D74CQ39741633-65B4315D-3EB3-494C-8CC6-AF6EFB95A52DQ39815157-65AC1D7B-AB09-4AC7-9AE1-7708BE62999CQ39837710-60514702-A84E-4A38-84F4-C88C1AB16F56Q39882265-0608E3F4-FE15-495C-849F-F0BE97D33404
P50
description
Researcher
@en
onderzoeker
@nl
հետազոտող
@hy
name
José M. Padrón
@ast
José M. Padrón
@en
José M. Padrón
@es
José M. Padrón
@sl
type
label
José M. Padrón
@ast
José M. Padrón
@en
José M. Padrón
@es
José M. Padrón
@sl
altLabel
Jose M. Padron-Carrillo
@en
prefLabel
José M. Padrón
@ast
José M. Padrón
@en
José M. Padrón
@es
José M. Padrón
@sl
P1053
H-5240-2011
P106
P1153
7003856521
P1960
EDAYWm0AAAAJ
P21
P31
P3829
P496
0000-0002-7488-1774